Literature DB >> 28978659

Polycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population.

Heidi J Nurmonen1, Terhi Huttunen1, Jukka Huttunen1, Mitja I Kurki1, Katariina Helin1, Timo Koivisto1, Mikael von Und Zu Fraunberg1, Juha E Jääskeläinen1, Antti E Lindgren2.   

Abstract

OBJECTIVE: To define the association of autosomal dominant polycystic kidney disease (ADPKD) with the characteristics of aneurysmal subarachnoid hemorrhage (aSAH) and unruptured intracranial aneurysm (IA) disease.
METHODS: We fused data from the Kuopio Intracranial Aneurysm database (n = 4,436 IA patients) and Finnish nationwide registries into a population-based series of 53 IA patients with ADPKD to compare the aneurysm- and patient-specific characteristics of IA disease in ADPKD and in the general IA population, and to identify risks for de novo IA formation.
RESULTS: In total, there were 33 patients with ADPKD with aSAH and 20 patients with ADPKD with unruptured IAs. The median size of ruptured IAs in ADPKD was significantly smaller than in the general population (6.00 vs 8.00 mm) and the proportion of small ruptured IAs was significantly higher (31% vs 18%). Median age at aSAH was 42.8 years, 10 years younger than in the general IA population. Multiple IAs were present in 45% of patients with ADPKD compared to 28% in the general IA population. Cumulative risk of de novo IA formation was 1.3% per patient-year (vs 0.2% in the general IA population). Hazard for de novo aneurysm formation was significantly elevated in patients with ADPKD (Cox regression hazard ratio 7.7, 95% confidence interval 2.8-20; p < 0.0005).
CONCLUSIONS: Subarachnoid hemorrhage occurs at younger age and from smaller IAs in patients with ADPKD and risk for de novo IAs is higher than in the general Eastern Finnish population. ADPKD should be considered as an indicator for long-term angiographic follow-up in patients with diagnosed IAs.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 28978659     DOI: 10.1212/WNL.0000000000004597

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Adrien Flahault; Dominique Joly
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-19       Impact factor: 8.237

2.  Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Comparison of Management Approaches.

Authors:  D Andrew Wilkinson; Michael Heung; Amrit Deol; Neeraj Chaudhary; Joseph J Gemmete; B Gregory Thompson; Aditya S Pandey
Journal:  Neurosurgery       Date:  2019-06-01       Impact factor: 4.654

3.  Clinical features of ischemic complications after unruptured middle cerebral artery aneurysm clipping: patients and radiologically related factors.

Authors:  Heui Seung Lee; Moinay Kim; Jung Cheol Park; Jae Sung Ahn; Seungjoo Lee; Wonhyoung Park
Journal:  Neurosurg Rev       Date:  2021-01-19       Impact factor: 3.042

4.  New Pathophysiological Considerations on Cerebral Aneurysms.

Authors:  Keun-Hwa Jung
Journal:  Neurointervention       Date:  2018-08-31

5.  Association of Intracranial Aneurysms With Aortic Aneurysms in 125 Patients With Fusiform and 4253 Patients With Saccular Intracranial Aneurysms and Their Family Members and Population Controls.

Authors:  Arttu Kurtelius; Nelli Väntti; Behnam Rezai Jahromi; Olli Tähtinen; Hannu Manninen; Juha Koskenvuo; Riikka Tulamo; Satu Kotikoski; Heidi Nurmonen; Olli-Pekka Kämäräinen; Terhi Huttunen; Jukka Huttunen; Mikael von Und Zu Fraunberg; Timo Koivisto; Juha E Jääskeläinen; Antti E Lindgren
Journal:  J Am Heart Assoc       Date:  2019-09-05       Impact factor: 5.501

6.  Assessing the Risk of Intracranial Aneurysm Rupture Using Morphological and Hemodynamic Biomarkers Evaluated from Magnetic Resonance Fluid Dynamics and Computational Fluid Dynamics.

Authors:  Roshani Perera; Haruo Isoda; Kenta Ishiguro; Takashi Mizuno; Yasuo Takehara; Masaki Terada; Chiharu Tanoi; Takehiro Naito; Harumi Sakahara; Hisaya Hiramatsu; Hiroki Namba; Takashi Izumi; Toshihiko Wakabayashi; Takafumi Kosugi; Yuki Onishi; Marcus Alley; Yoshiaki Komori; Mitsuru Ikeda; Shinji Naganawa
Journal:  Magn Reson Med Sci       Date:  2020-01-17       Impact factor: 2.471

7.  Clinical condition of 120 patients alive at 3 years after poor-grade aneurysmal subarachnoid hemorrhage.

Authors:  Anniina H Autio; Juho Paavola; Joona Tervonen; Maarit Lång; Terhi J Huuskonen; Jukka Huttunen; Virve Kärkkäinen; Mikael von Und Zu Fraunberg; Antti E Lindgren; Timo Koivisto; Juha E Jääskeläinen; Olli-Pekka Kämäräinen
Journal:  Acta Neurochir (Wien)       Date:  2021-02-25       Impact factor: 2.216

8.  Development and validation of a novel nomogram to predict aneurysm rupture in patients with multiple intracranial aneurysms: a multicentre retrospective study.

Authors:  Xin Feng; Xin Tong; Aihua Liu; Daming Wang; Fei Peng; Hao Niu; Peng Qi; Jun Lu; Yang Zhao; Weitao Jin; Zhongxue Wu; Yuanli Zhao
Journal:  Stroke Vasc Neurol       Date:  2021-02-05

9.  MR Brain Screening in ADPKD Patients : To Screen or not to Screen?

Authors:  I Capelli; M Zoli; M Righini; L Faccioli; V Aiello; L Spinardi; D Gori; F Friso; A Rustici; C Bortolotti; C Graziano; V Mantovani; N Sciascia; D Mazzatenta; M Seri; M Pastore Trossello; G La Manna
Journal:  Clin Neuroradiol       Date:  2021-09-29       Impact factor: 3.649

Review 10.  Preventive screening for intracranial aneurysms.

Authors:  Gabriel Je Rinkel; Ynte M Ruigrok
Journal:  Int J Stroke       Date:  2021-06-17       Impact factor: 5.266

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.